INHIBITION OF GROWTH HORMONE RELEASE IN HUMANS BY SOMATOSTATIN.
- 1 October 1973
- journal article
- other
- Published by The Endocrine Society in Journal of Clinical Endocrinology & Metabolism
- Vol. 37 (4) , 632-634
- https://doi.org/10.1210/jcem-37-4-632
Abstract
Synthetic (linear) somatostatin (SRIF, somatotropin-release inhibiting factor) abolished the elevation of serum GH concentration induced in normal human subjects by the administration of L-dopa and arginine. Within the dose used (250 μg, iv and 500 μg constant infusion) somatostatin. did not inhibit the rise in circulating PRL normally observed with arginine infusion nor did it modify basal levels of serum GH, TSH, PRL, FSH and LH.Keywords
This publication has 0 references indexed in Scilit: